|
Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Cystic Fibrosis
|
NHLBI
|
7K08HL071613-03
|
|
Novel Strategies for Aerosolized AAV Gene Therapy
|
FISCHER, ANNE
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$128,250
|
Cystic Fibrosis
|
NIAID
|
1K22AI065425-01A2
|
|
Eicosanoid Production By Infected Lung Epithelial Cells
|
HURLEY, BRYAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$161,304
|
Cystic Fibrosis
|
NIAID
|
4R37AI015940-29
|
|
Iron and O2 in the Regulation of P. aeruginosa Virulence
|
VASIL, MICHAEL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$659,058
|
Cystic Fibrosis
|
NHLBI
|
1K23HL089118-01
|
|
Infection and Inflammation in Pediatric Catheter Related Venous Thrombosis
|
RAFFINI, LESLIE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$155,852
|
Cystic Fibrosis
|
NHLBI
|
5R01HL073870-04
|
|
Limiting Inflammation in the CF Lung
|
DAVIS, PAMELA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$508,294
|
Cystic Fibrosis
|
NHLBI
|
5R01HL073989-04
|
|
Calcium Dependent Signaling Pathways in Epithelial Cells
|
PRINCE, ALICE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$381,642
|
Cystic Fibrosis
|
NHLBI
|
5R01HL075540-04
|
|
Nitric Oxide Modulation of CFTR Expression and Function
|
MATALON, SADIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$344,900
|
Cystic Fibrosis
|
NHLBI
|
5R01HL079442-04
|
|
Proteomic Profiling of CFTR Protein Interaction
|
YATES, JOHN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$449,200
|
Cystic Fibrosis
|
NIDDK
|
5R01DK058046-08
|
|
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate
|
RUBENSTEIN, RONALD
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$305,415
|
Cystic Fibrosis
|
NIDDK
|
5R01DK057718-06
|
|
Trafficking and Regulation of the Epithelial Na+ Channel
|
JOHNSON, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$238,669
|
Cystic Fibrosis
|
NIDDK
|
5R01DK075048-02
|
|
Mechanisms and Relevance of ENaC Regulation by AMP-Activated Kinase
|
HALLOWS, KENNETH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$237,666
|
Cystic Fibrosis
|
NIAID
|
5R01AI048917-07
|
|
Virulence and Immunity to Mucoid P. aeruginosa
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$380,786
|
Cystic Fibrosis
|
NIAID
|
5R01AI057754-03
|
|
Transcription Regulation in Pseudomonas aeruginosa
|
DOVE, SIMON
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$362,208
|
Cystic Fibrosis
|
NHLBI
|
5R01HL081825-03
|
|
Anti-inflammatory role of MUC1 mucin
|
KIM, KWANG
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
NM
|
$497,638
|
Cystic Fibrosis
|
NIAID
|
5K22AI065828-02
|
|
Small molecule inhibitors of bacterial secretion system
|
LEE, VINCENT
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$108,000
|
Cystic Fibrosis
|
NIAID
|
5R21AI072291-02
|
|
Transcytosis of Flagellin Across Airway Epithelia
|
LILLEHOJ, ERIK
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$182,098
|
Cystic Fibrosis
|
NIDDK
|
5R01DK051870-11
|
|
CFTR Processing in the Endoplasmic Reticulum
|
RIORDAN, JOHN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$348,866
|
Cystic Fibrosis
|
NIDDK
|
5R01DK034108-22
|
|
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening
|
FARRELL, PHILIP
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$496,723
|
Cystic Fibrosis
|
NIGMS
|
5R01GM056981-12
|
|
Detection of folding defects in mutant CFTR by ERQC
|
CYR, DOUGLAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$311,028
|
Cystic Fibrosis
|
NIDDK
|
1R01DK075309-01A1
|
|
Keeping CFTR in its Place: An Integrated Small-Molecule Approach
|
MADDEN, DEAN
|
DARTMOUTH COLLEGE
|
NH
|
$418,288
|
Cystic Fibrosis
|
NEI
|
5R01EY016144-04
|
|
Pathogenesis of P. aeruginosa corneal infection
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$387,085
|
Cystic Fibrosis
|
NIDCR
|
5R01DE014080-06
|
|
Membrane Bound Mucins in Salivary Glands and Saliva
|
OFFNER, GWYNNETH
|
BOSTON MEDICAL CENTER
|
MA
|
$299,946
|
Cystic Fibrosis
|
NHLBI
|
5R01HL058340-12
|
|
Mechanisms of rAAV Transduction in the Airway
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$349,641
|
Cystic Fibrosis
|
NIAID
|
1R01AI076272-01
|
|
Studies on the Pseudomonas aeruginosa cell-to-cell signal PQS
|
PESCI, EVERETT
|
EAST CAROLINA UNIVERSITY
|
NC
|
$321,750
|
Cystic Fibrosis
|
NIAID
|
5R01AI069007-03
|
|
Phase-variable gene expression in Pseudomonas aeruginosa
|
DOVE, SIMON
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$362,208
|
Cystic Fibrosis
|
NIAID
|
1R03AI076561-01
|
|
Pseudomonas biofilms and persistence
|
WOZNIAK, DANIEL
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$74,000
|
Cystic Fibrosis
|
NIGMS
|
1K99GM083147-01
|
|
Spatial Organization of Chemotaxis Systems in Pseudomonas aeruginosa
|
BARDY, SONIA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$89,332
|
Cystic Fibrosis
|
NIAID
|
1K08AI076671-01
|
|
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
|
STOLTZ, DAVID
|
UNIVERSITY OF IOWA
|
IA
|
$126,267
|
Cystic Fibrosis
|
NIDDK
|
1R21DK080371-01
|
|
CCK-58 and the Two Component Paradigm for Exocrine Pancreatic Secretion
|
GREEN, GARY
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$185,000
|
Cystic Fibrosis
|
NIAID
|
5R01AI061396-04
|
|
The matrix of Pseudomonas aeruginosa biofilms
|
WOZNIAK, DANIEL
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$494,196
|
Cystic Fibrosis
|
NINR
|
5R01NR009285-02
|
|
Self-Regulated Exercise in CF: A Randomized Trial
|
ORENSTEIN, DAVID
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$353,051
|
Cystic Fibrosis
|
NHLBI
|
5R01HL058398-11
|
|
CFTR and infection of cystic fibrosis patients
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$388,400
|
Cystic Fibrosis
|
NHLBI
|
5R01HL079312-04
|
|
Lipid Mediators and Dysregulated Inflammation in CF
|
KARP, CHRISTOPHER
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$400,849
|
Cystic Fibrosis
|
NIDDK
|
5R01DK054354-10
|
|
Epithelial Na Channels: Structure-Function Studies
|
KLEYMAN, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$299,662
|
Cystic Fibrosis
|
NHLBI
|
1R01HL087997-01A1
|
|
Motivating Improved Self-Management Among Older Teens & Adults with CF
|
RIEKERT, KRISTIN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$547,987
|
Cystic Fibrosis
|
NIAID
|
5R01AI064512-03
|
|
Phages of Burkholderia cepacia:Biology and Therapeutics
|
YOUNG, RYLAND
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$316,837
|
Cystic Fibrosis
|
NIAID
|
1R01AI069116-01A1
|
|
Cyclic AMP Signaling in Pseudomonas aeruginosa Virulence
|
WOLFGANG, MATTHEW
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$329,921
|
Cystic Fibrosis
|
NIEHS
|
1R01ES014701-01A2
|
|
Epithelial Sodium Channels and Pulmonary Toxicity of Zinc
|
SHENG, SHAOHU
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$269,550
|
Cystic Fibrosis
|
NHLBI
|
2R01HL058334-09A1
|
|
Control of P. aeruginosa algD transcription
|
WOZNIAK, DANIEL
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$333,000
|
Cystic Fibrosis
|
NHLBI
|
2R01HL059337-09A2
|
|
S-nitrosothiol breakdown by airway epithelial cells
|
GASTON, BENJAMIN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$369,510
|
Cystic Fibrosis
|
NHLBI
|
5R37HL036982-22
|
|
Mechanism of Oxidant-Induced Respiratory Mucin Secretion
|
ADLER, KENNETH
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
NC
|
$374,801
|
Cystic Fibrosis
|
NHGRI
|
1R21HG004252-01A1
|
|
Developing a Family-Centered Approach for Genetic Counseling: A New Paradigm
|
TLUCZEK, AUDREY
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$178,487
|
Cystic Fibrosis
|
NHLBI
|
1R21HL087833-01A1
|
|
Genes associated with epidemic Burkholderia cenocepacia
|
LIPUMA, JOHN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$240,281
|
Cystic Fibrosis
|
NHLBI
|
1K08HL087932-01A1
|
|
Altered Proteolytic Processing of ENaC in the Pathogenesis of Cystic Fibrosis
|
MYERBURG, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$124,929
|
Cystic Fibrosis
|
NIAID
|
5R01AI050812-06
|
|
Regulation of Ps. aeruginosa Virulence Factors by AlgR
|
SCHURR, MICHAEL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$250,680
|
Cystic Fibrosis
|
NHLBI
|
5R01HL066125-07
|
|
Regulation of Airway Lactoperoxidase Host Defense
|
CONNER, GREGORY
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$334,267
|
Cystic Fibrosis
|
NHLBI
|
5R01HL081763-03
|
|
Epithelial Cell Cycle Regulation by Elastase
|
FISCHER, BERNARD
|
DUKE UNIVERSITY
|
NC
|
$227,214
|
Cystic Fibrosis
|
NHLBI
|
5R01HL047125-16
|
|
Regulation of MUC1 mucin during airway inflammation
|
KIM, KWANG
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
NM
|
$496,162
|
Cystic Fibrosis
|
NHLBI
|
5R21HL084341-02
|
|
Polymicrobial disease and inflammation in cystic fibrosis
|
LIOU, THEODORE
|
UNIVERSITY OF UTAH
|
UT
|
$186,875
|
Cystic Fibrosis
|
NHLBI
|
5R01HL084042-03
|
|
Electroyte Transport in Small Airways
|
QUINTON, PAUL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$375,049
|
Cystic Fibrosis
|
NHLBI
|
5R01HL068927-07
|
|
Genetic Modifiers of CF: Sibling Study
|
CUTTING, GARRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$774,032
|
Cystic Fibrosis
|
NIAID
|
5R01AI022535-24
|
|
Acquired Immunity and Vaccination for P. aeruginosa
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$341,698
|
Cystic Fibrosis
|
NHLBI
|
5R01HL066548-06
|
|
MNEI/SerpinB1: A modulator of innate pulmonary defense
|
REMOLD-O'DONNELL, EILEEN
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$473,500
|
Cystic Fibrosis
|
NIDDK
|
5R01DK051767-12
|
|
Mechanisms, Structure, and Regulation of CFTR's NBD's
|
GADSBY, DAVID
|
ROCKEFELLER UNIVERSITY
|
NY
|
$332,136
|
Cystic Fibrosis
|
NHLBI
|
5R01HL083047-02
|
|
Aerosol delivery of HDAd into Primate Lungs: Preclinical CF Gene Therapy Studies
|
NG, PHILIP
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$704,125
|
Cystic Fibrosis
|
NICHD
|
5R01HD050463-02
|
|
Promoting Self-Management: CF as Model Case
|
ROBINSON, WALTER
|
EDUCATION DEVELOPMENT CENTER, INC.
|
MA
|
$334,062
|
Cystic Fibrosis
|
NIAID
|
5R01AI019146-24
|
|
Activation of Alginate Genes in Pseudomonas aeruginosa
|
OHMAN, DENNIS
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$323,381
|
Cystic Fibrosis
|
NHLBI
|
5R01HL058812-11
|
|
Regulation of ENaC Trafficking
|
SNYDER, PETER
|
UNIVERSITY OF IOWA
|
IA
|
$331,875
|
Cystic Fibrosis
|
NHLBI
|
5R01HL080322-04
|
|
Airway Epithelial Adaptation to Infectious Stimuli
|
RANDELL, SCOTT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$346,086
|
Cystic Fibrosis
|
NIDDK
|
1R41DK076516-01A2
|
|
A novel approach for gene therapy
|
MAAS, STEFAN
|
ATIGEN
|
PA
|
$139,916
|
Cystic Fibrosis
|
NIAID
|
5R01AI063433-03
|
|
Function of MVFR in Pseudomonas aeruginosa virulence
|
RAHME, LAURENCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$380,879
|
Cystic Fibrosis
|
NHLBI
|
1R43HL091658-01
|
|
Correction of dF508 Cystic Fibrosis Using an Engineered Nuclease
|
JANTZ, DEREK
|
PRECISION BIOSCIENCES, INC.
|
NC
|
$100,000
|
Cystic Fibrosis
|
NEI
|
5R01EY003306-29
|
|
"Mucins of the Ocular Surface"
|
GIPSON, ILENE
|
SCHEPENS EYE RESEARCH INSTITUTE
|
MA
|
$672,758
|
Cystic Fibrosis
|
NIAID
|
5R21AI070188-02
|
|
Novel Targets for Treatment of Pseudomonas aeruginosa
|
LISTER, PHILIP
|
CREIGHTON UNIVERSITY
|
NE
|
$175,967
|
Cystic Fibrosis
|
NIAID
|
5R01AI030162-17
|
|
Acellular vaccines against bacterial pathogens
|
BARBIERI, JOSEPH
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$317,071
|
Cystic Fibrosis
|
NHLBI
|
5R01HL063302-08
|
|
Airway Submucosal Glands and Cystic Fibrosis Disease
|
BALLARD, STEPHEN
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$276,869
|
Cystic Fibrosis
|
NIAID
|
5R41AI072912-02
|
|
TLR5 Antagonists for Infectious Disease Therapy
|
LORY, STEPHEN
|
MICROBIOTIX, INC
|
MA
|
$300,000
|
Cystic Fibrosis
|
NIAMS
|
1F32AR054226-01A2
|
|
Mechanisms of Cystic Fibrosis-induced Osteoporosis
|
GENETOS, DAMIAN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$51,278
|
Cystic Fibrosis
|
NIAID
|
5R01AI067856-03
|
|
Silver carbene complexes as treatment of CF lung disease
|
CANNON, CAROLYN
|
WASHINGTON UNIVERSITY
|
MO
|
$357,064
|
Cystic Fibrosis
|
NHLBI
|
5R01HL077382-04
|
|
Bacteria-Epithelial Cell Cytoskeleton Interaction
|
BRODY, STEVEN
|
WASHINGTON UNIVERSITY
|
MO
|
$326,412
|
Cystic Fibrosis
|
NHLBI
|
5R44HL081951-03
|
|
Breath Analysis using Quantum Cascade Lasers
|
SHORTER, JOANNE
|
AERODYNE RESEARCH, INC
|
MA
|
$382,539
|
Cystic Fibrosis
|
NIDDK
|
5R01DK066368-05
|
|
Genetic Modifiers of CF Liver Disease
|
KNOWLES, MICHAEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$614,590
|
Cystic Fibrosis
|
NIAID
|
5R01AI067653-02
|
|
Polymyxin-resistant Pseudomonas in CF Lung Infection
|
MOSKOWITZ, SAMUEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$571,018
|
Cystic Fibrosis
|
FIC
|
5R03TW007829-02
|
|
Opening and Closing Mechanisms of CFTR Channels
|
CSANADY, LASZLO
|
SEMMELWEIS UNIVERSITY
|
HUNGAR
|
$32,486
|
Cystic Fibrosis
|
NIDDK
|
5R01DK058318-09
|
|
Accessing the Airway for Cystic Fibrosis Gene Therapy
|
DAVIS, PAMELA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$334,100
|
Cystic Fibrosis
|
NIDCD
|
5R01DC004562-10
|
|
Up-regulation of Mucin Gene Transcription-Otitis Media
|
LI, JIAN-DONG
|
UNIVERSITY OF ROCHESTER
|
NY
|
$321,185
|
Cystic Fibrosis
|
NIDCR
|
5R01DE011691-12
|
|
Structure and Function of Human Salivary Mucins
|
OFFNER, GWYNNETH
|
BOSTON MEDICAL CENTER
|
MA
|
$322,716
|
Cystic Fibrosis
|
NIGMS
|
1SC1AI081376-01
|
|
Regulation of P. aeruginosa PoxB Oxacillinase by AmpR and a Two-Component System
|
MATHEE, KALAI
|
FLORIDA INTERNATIONAL UNIVERSITY
|
FL
|
$295,800
|
Cystic Fibrosis
|
NHLBI
|
1R21HL091808-01
|
|
Allele-Specific Repair of the CFTR DeltaF508 Mutation using Zinc Finger Nucleases
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$215,500
|
Cystic Fibrosis
|
NIDDK
|
5K23DK075788-03
|
|
Clinical and Mechanistic Features of Premature Termination Codon Suppression
|
ROWE, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$128,844
|
Cystic Fibrosis
|
NIAID
|
5R01AI068112-03
|
|
Live Attenuated Recombinant Bacterial Delivery of Polysaccharide Vaccine Antigens
|
GOLDBERG, JOANNA
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$358,958
|
Cystic Fibrosis
|
NIDDK
|
5K08DK073298-03
|
|
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
|
DIMAGNO, MATTHEW
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$132,300
|
Cystic Fibrosis
|
NIGMS
|
5R01GM075061-03
|
|
Endoplasmic Reticulum (ER) Associated Degradation of Membrane Proteins in Yeast
|
BRODSKY, JEFFREY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$241,814
|
Cystic Fibrosis
|
NHLBI
|
5R01HL089399-02
|
|
Mucociliary Function in Chronic Bronchitis
|
SALATHE, MATTHIAS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$382,500
|
Cystic Fibrosis
|
NIDDK
|
5K24DK059973-08
|
|
Behavioral Treatment for Dietary Adherence in Children
|
POWERS, SCOTT
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$168,356
|
Cystic Fibrosis
|
NIDDK
|
5R01DK051817-12
|
|
Serous Cell Secretion and Cystic Fibrosis Lung Disease
|
WINE, JEFFREY
|
STANFORD UNIVERSITY
|
CA
|
$325,416
|
Cystic Fibrosis
|
NIAID
|
5R01AI067530-03
|
|
Biochemistry of Phenazine Production in Pseudomonas aeruginosa
|
PARSONS, JAMES
|
UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
|
MD
|
$282,907
|
Cystic Fibrosis
|
NIDDK
|
1K01DK080847-01
|
|
Mechanotransduction of shear stress: from ATP release to CFTR regulation
|
BUTTON, BRIAN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$97,951
|
Cystic Fibrosis
|
NIDCD
|
5R01DC007903-03
|
|
CYTOKINE INFLAMMATORY MEDIATORS AND MUCIN REGULATION IN MIDDLE EAR EPITHELIUM
|
KERSCHNER, JOSEPH
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$362,985
|
Cystic Fibrosis
|
NIDDK
|
7R01DK075302-03
|
|
Correction of defective deltaF508-CFTR processing in cystic fibrosis
|
LUKACS, GERGELY
|
MCGILL UNIVERSITY
|
CANADA
|
$210,680
|
Cystic Fibrosis
|
NIDDK
|
5R01DK048816-12
|
|
CFTR and acid-base transporters of intestinal epithelia
|
CLARKE, LANE
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$284,522
|
Cystic Fibrosis
|
NIDDK
|
5R01DK072126-03
|
|
MALNUTRITION AND LUNG DISEASE IN CYSTIC FIBROSIS
|
LAI, HUICHUAN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$253,368
|
Cystic Fibrosis
|
NHLBI
|
2R01HL060644-09A1
|
|
Phosphorylation of ciliary target proteins
|
SALATHE, MATTHIAS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$382,500
|
Cystic Fibrosis
|
NHLBI
|
5R01HL047122-17
|
|
CFTR/Regulation of CL Secretion in Normal and CF Airways
|
GUGGINO, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$398,110
|
Cystic Fibrosis
|
NHLBI
|
5R01HL082657-03
|
|
Delivering antiproteases to the bronchiectatic airway
|
FERKOL, THOMAS
|
WASHINGTON UNIVERSITY
|
MO
|
$295,184
|
Cystic Fibrosis
|
NHLBI
|
5R01HL077844-04
|
|
CFTR Delivery to Ciliated Airway Cells by PIV Vectors
|
PICKLES, RAYMOND
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$344,505
|
Cystic Fibrosis
|
NHLBI
|
5R01HL077902-04
|
|
IL-17 Mediated MUC Gene Expression in Airway Epithelium
|
WU, REEN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$324,278
|
Cystic Fibrosis
|
NIAID
|
5R01AI060841-05
|
|
Mechanism of Enzymes Mediating Resistance in Pseudomonas
|
SOUSA, MARCELO
|
UNIVERSITY OF COLORADO AT BOULDER
|
CO
|
$272,408
|
Cystic Fibrosis
|
NHLBI
|
5R01HL053445-11
|
|
Gating of CFTR Cl Channels by ATP Hydrolysis
|
HWANG, TZYH-CHANG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$329,972
|
Cystic Fibrosis
|
NHLBI
|
5R01HL058341-11
|
|
Regulation of CFTR by syntaxin and N-sec 1 isoforms
|
KIRK, KEVIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$326,250
|
Cystic Fibrosis
|
NIAID
|
2R01AI055042-06
|
|
Regulation of Pseudomonas aeruginosa type III secretion
|
YAHR, TIMOTHY
|
UNIVERSITY OF IOWA
|
IA
|
$300,000
|
Cystic Fibrosis
|
NHLBI
|
1R01HL085655-01A2
|
|
Role of Metalloproteinases in Mucin Overproduction in COPD
|
LEIKAUF, GEORGE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$353,187
|
Cystic Fibrosis
|
NIDDK
|
1R01DK077065-01A2
|
|
Functional Relevance of CFTR Trafficking in Vivo to Intestinal Disease
|
AMEEN, NADIA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$320,344
|
Cystic Fibrosis
|
NIAID
|
5R03AI074779-02
|
|
NMR studies of the enzyme PMM/PGM from P. aeruginosa
|
BEAMER, LESA
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$73,330
|
Cystic Fibrosis
|
NIDDK
|
2R37DK049835-13
|
|
DEVELOPMENT OF MEMBRANE PROTEIN STRUCTURE
|
THOMAS, PHILIP
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$333,625
|
Cystic Fibrosis
|
NIDDK
|
2R01DK051818-09A2
|
|
Biogenesis and Molecular Pathogenesis of CFTR
|
SKACH, WILLIAM
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$308,000
|
Cystic Fibrosis
|
NIAID
|
5R41AI072866-02
|
|
Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis
|
PATZER, ERIC
|
ARIDIS PHARMACEUTICALS, LLC
|
CA
|
$243,632
|
Cystic Fibrosis
|
NHLBI
|
5R01HL082504-04
|
|
Mucin Gene Regulation by Elastase and Oxidants
|
VOYNOW, JUDITH
|
DUKE UNIVERSITY
|
NC
|
$295,832
|
Cystic Fibrosis
|
NIGMS
|
2R01GM036823-18A1
|
|
Role of Ion Channel in Mononuclear Phagocyte Activation
|
NELSON, DEBORAH
|
UNIVERSITY OF CHICAGO
|
IL
|
$299,486
|
Cystic Fibrosis
|
NIDDK
|
5R21DK076552-02
|
|
Novel hybrid AAV vectors for cystic fibrosis gene therapy
|
DUAN, DONGSHENG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$214,736
|
Cystic Fibrosis
|
NHLBI
|
5K08HL081269-03
|
|
Mechanisms of Intracellular Iron Accumulation in Cystic Fibrosis
|
TURI, JENNIFER
|
DUKE UNIVERSITY
|
NC
|
$126,225
|
Cystic Fibrosis
|
NIAID
|
5U01AI069032-03
|
|
Immunization Against Pseudomonas aeruginosa by Modified Ad Vectors
|
WORGALL, STEFAN
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$419,669
|
Cystic Fibrosis
|
NHLBI
|
1R21HL085112-01A2
|
|
Regulation of Epithelial Sodium Channel by CFTR chloride channel
|
BERDIEV, BAKHROM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$193,750
|
Cystic Fibrosis
|
NHLBI
|
5R01HL086496-02
|
|
Struture snd Dynamic Determinants of Ion Channel Assembly by Adapter Proteins
|
BU, ZIMEI
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$384,750
|
Cystic Fibrosis
|
NHLBI
|
5R01HL073856-06
|
|
Role of airway submucosal glands in CF lung disease
|
VERKMAN, ALAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$386,250
|
Cystic Fibrosis
|
NHLBI
|
5U01HL080310-05
|
|
Early Antipseudomonal Therapy in Cystic Fibrosis
|
RAMSEY, BONNIE
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$836,733
|
Cystic Fibrosis
|
NIDDK
|
5U01HL080310-05
|
|
Early Antipseudomonal Therapy in Cystic Fibrosis
|
RAMSEY, BONNIE
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$318,429
|
Cystic Fibrosis
|
NHLBI
|
5K08HL081537-02
|
|
IL-23: Actions and Regulation in Pseudomonas aeruginosa Pulmonary Infection
|
DUBIN, PATRICIA
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$107,619
|
Cystic Fibrosis
|
NIAID
|
1R21AI075300-01A1
|
|
Role of Non-Coding RNAs in P. aeruginosa Biofilm Development
|
FRANKLIN, MICHAEL
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$213,750
|
Cystic Fibrosis
|
NHLBI
|
2R01HL033152-22A1
|
|
Role of MUC5AC Mucins in Airway Disease
|
ROSE, MARY
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$332,000
|
Cystic Fibrosis
|
NHLBI
|
2R01HL073159-05A1
|
|
BASIS OF CHRONIC MUCOUS CELL METAPLASIA
|
HOLTZMAN, MICHAEL
|
WASHINGTON UNIVERSITY
|
MO
|
$387,443
|
Cystic Fibrosis
|
NHLBI
|
5R01HL077546-03
|
|
The Virtual Lung Project: Integrated Modeling of Epithelial Fluid Flows
|
SUPERFINE, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$692,018
|
Cystic Fibrosis
|
NHLBI
|
5R01HL080561-03
|
|
CFTR Protein Interactions
|
STUTTS, MONROE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$317,782
|
Cystic Fibrosis
|
NIAID
|
7R01AI047938-08
|
|
Pseudomonas aeruginosa lipid A
|
ERNST, ROBERT
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$321,486
|
Cystic Fibrosis
|
NIDDK
|
5R01DK045881-14
|
|
Regulation of CFTR Trafficking
|
STANTON, BRUCE
|
DARTMOUTH COLLEGE
|
NH
|
$334,309
|
Cystic Fibrosis
|
NIDDK
|
5R01DK056796-09
|
|
New paradigms of CFTR regulation
|
KIRK, KEVIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$277,163
|
Cystic Fibrosis
|
NIDDK
|
5R01DK053051-09
|
|
Regulation of Proinflammatory Signaling Pathways in CFTR
|
POLLARD, HARVEY
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$295,165
|
Cystic Fibrosis
|
NIDDK
|
5R01DK054915-09
|
|
Behavioral & Nutrition Tx to Help CF Preschoolers Grow
|
POWERS, SCOTT
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$557,994
|
Cystic Fibrosis
|
NIDDK
|
5R01DK045880-16
|
|
CFTR-Ion Conduction and Gating Mechanisms
|
DAWSON, DAVID
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$365,855
|
Cystic Fibrosis
|
NIBIB
|
5R03EB006892-02
|
|
Sustained Release Pulmonary Delivery for Improved Cystic Fibrosis Treatment
|
SMYTH, HUGH
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$73,500
|
Cystic Fibrosis
|
NIGMS
|
5R01GM078186-03
|
|
ER export and the quality control checkpoint during membrane protein biogenesis
|
MILLER, ELIZABETH
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$290,891
|
Cystic Fibrosis
|
NIDDK
|
5K01DK075408-03
|
|
Molecular Physiology and Pharmacology of CFTR
|
BOMPADRE, SILVIA
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$109,665
|
Cystic Fibrosis
|
NIDDK
|
5K24DK059492-08
|
|
Behavioral Rx & Nutrition in Pediatric Chronic Disease
|
STARK, LORI
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$177,284
|
Cystic Fibrosis
|
NIEHS
|
5R01ES014448-04
|
|
Lung epithelial cell survival signaling in ozone in cystic fibrosis and normals
|
WHITE, CARL
|
NATIONAL JEWISH HEALTH
|
CO
|
$309,849
|
Cystic Fibrosis
|
NHLBI
|
5F32HL085993-03
|
|
Identifying host factors in Pseudomonas lung damage
|
MORALES, CHRISTINA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$48,796
|
Cystic Fibrosis
|
NHLBI
|
5K08HL081080-03
|
|
Inhibition of chloride secretion by cigarette smoke
|
KREINDLER, JAMES
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$132,219
|
Cystic Fibrosis
|
NIBIB
|
5R01EB003558-02
|
|
New Gene Vectors for Cystic Fibrosis (CF): Extra- & Intracellular Barriers
|
HANES, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$356,988
|
Cystic Fibrosis
|
NIDDK
|
5R01DK070848-04
|
|
The Cystic Fibrosis Gene and Chronic Pancreatitis
|
COHN, JONATHAN
|
DUKE UNIVERSITY
|
NC
|
$290,844
|
Cystic Fibrosis
|
NIDDK
|
5R44DK060302-04
|
|
Organized Lipid Matrix: Fatty Acids and Choline in Cystic Fibrosis
|
SHAW, WALTER
|
AVANTI POLAR LIPIDS, INC.
|
AL
|
$1,412,666
|
Cystic Fibrosis
|
NIAID
|
5R01AI072327-02
|
|
CFTR Expression and Function in Human Neutrophils
|
WANG, GUOSHUN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$344,835
|
Cystic Fibrosis
|
NHLBI
|
1P01HL091842-01
|
0001
|
Airway physiology in a porcine model of cystic fibrosis
|
WELSH, MICHAEL
|
UNIVERSITY OF IOWA
|
IA
|
$258,639
|
Cystic Fibrosis
|
NHLBI
|
1P01HL091842-01
|
0002
|
Early lung inflammation in a porcine model of cystic fibrosis
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$293,233
|
Cystic Fibrosis
|
NHLBI
|
1P01HL091842-01
|
0003
|
Airway submucosal gland function in a porcine model of cystic fibrosis
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$333,320
|
Cystic Fibrosis
|
NHLBI
|
1P01HL091842-01
|
0004
|
Early airway infection in a porcne model of cystic fibrosis
|
ZABNER, JOSEPH
|
UNIVERSITY OF IOWA
|
IA
|
$288,090
|
Cystic Fibrosis
|
NHLBI
|
1P01HL091842-01
|
9001
|
Animal Core
|
BROGDEN, KIM
|
UNIVERSITY OF IOWA
|
IA
|
$689,889
|
Cystic Fibrosis
|
NHLBI
|
1P01HL091842-01
|
9002
|
Morphology Core
|
MEYERHOLZ, DAVID
|
UNIVERSITY OF IOWA
|
IA
|
$89,999
|
Cystic Fibrosis
|
NIGMS
|
1F32GM083568-01A1
|
|
Mechanisms of Sec61-Mediated Polytopic Protein Integration into the ER
|
CONTI, BRIAN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$49,646
|
Cystic Fibrosis
|
NHLBI
|
5R01HL065599-08
|
|
Mechanisms of Cutaneous Active Vasodilation
|
KELLOGG, DEAN
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$265,610
|
Cystic Fibrosis
|
NIAID
|
1F31AI078700-01
|
|
The role of exopolysaccharides in Pseudomonas aeruginosa virulence
|
BYRD, MATTHEW
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$40,972
|
Cystic Fibrosis
|
NIEHS
|
5R01ES015036-03
|
|
Shared Mechanisms of Pulmonary Lymphocyte Activation by Bacteria and Toxicants
|
BORCHERS, MICHAEL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$382,473
|
Cystic Fibrosis
|
NHLBI
|
5R01HL068890-08
|
|
Gene Modifiers in CF Lung Disease
|
KNOWLES, MICHAEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$702,547
|
Cystic Fibrosis
|
NIAID
|
5R01AI061695-02
|
|
Regulation of MUC19 by Th2 cytokine in airway epithelium
|
CHEN, YIN
|
THE HAMNER INSTITUTES
|
NC
|
$412,020
|
Cystic Fibrosis
|
NHLBI
|
5K25HL081533-02
|
|
Imaging of Pulmonary Mucociliary Clearance
|
CORCORAN, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$118,851
|
Cystic Fibrosis
|
NIEHS
|
5R21ES015841-02
|
|
Environmental Effects on Lung Function in Cystic Fibrosis Patients
|
GOSS, CHRISTOPHER
|
UNIVERSITY OF WASHINGTON
|
WA
|
$191,100
|
Cystic Fibrosis
|
NIAID
|
5R21AI073816-02
|
|
Regulation of Fatty Acid Biosynthesis and Degradation in Pseudomonas aeruginosa
|
HOANG, TUNG
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$203,656
|
Cystic Fibrosis
|
NIDDK
|
5F32DK080615-02
|
|
Rescue of CFTR-deltaF508 misfolding by pharmacological and genetic suppressors
|
TYLER, RYAN
|
STANFORD UNIVERSITY
|
CA
|
$49,646
|
Cystic Fibrosis
|
NIDDK
|
1R01DK081355-01
|
|
LIVE-CELL IMAGING OF CFTR OLIGOMERIZATION, TRAFFICKING AND INTERACTIONS
|
HAGGIE, PETER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$309,000
|
Cystic Fibrosis
|
NHLBI
|
1U01HL092931-01
|
|
Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS) - CCC - Lead Application
|
ROSENFELD, MARGARET
|
CHILDREN'S HOSPITAL AND REG MEDICAL CTR
|
WA
|
$531,674
|
Cystic Fibrosis
|
NHLBI
|
1U01HL092932-01
|
|
Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS) - DCC
|
KRONMAL, RICHARD
|
UNIVERSITY OF WASHINGTON
|
WA
|
$200,802
|
Cystic Fibrosis
|
NIAID
|
1R21AI079454-01
|
|
Stringent control of virulence gene expression in Pseudomonas aeruginosa
|
SCHUSTER, MARTIN
|
OREGON STATE UNIVERSITY
|
OR
|
$213,831
|
Cystic Fibrosis
|
NIAMS
|
1R15AR056463-01
|
|
Mucin expression in rheumatoid arthritis
|
VOLIN, MICHAEL
|
MIDWESTERN UNIVERSITY
|
IL
|
$193,277
|
Cystic Fibrosis
|
NHLBI
|
1R15HL093708-01
|
|
High mobility group box 1 (HMGB1) in the airway as a therapeutic target in CF
|
MANTELL, LIN
|
ST. JOHN'S UNIVERSITY
|
NY
|
$245,250
|
Cystic Fibrosis
|
NIAID
|
1R15AI079708-01
|
|
Mutators and Pseudomonas Genome Evolution in the CF-lung Enviornment
|
ROSENZWEIG, RAPHAEL
|
UNIVERSITY OF MONTANA
|
MT
|
$212,250
|
Cystic Fibrosis
|
NIGMS
|
2R01GM056665-10A1
|
|
Cyclic-di-GMP signaling in Pseudomonas aeruginosa
|
HARWOOD, CAROLINE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$337,769
|
Cystic Fibrosis
|
NIBIB
|
1R01EB006789-01A2
|
|
DNA Analysis in Multi-Phase Microfabricated Devices
|
BURNS, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$327,024
|
Cystic Fibrosis
|
NHLBI
|
1R01HL090767-01A1
|
|
Regulation of the Endocytic Trafficking of CFTR
|
SWIATECKA-URBAN, AGNIESZKA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$395,012
|
Cystic Fibrosis
|
NIGMS
|
1R01GM085785-01A1
|
|
Structural and biochemical characterization of the OprD membrane protein family
|
VAN DEN BERG, BERT
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$335,599
|
Cystic Fibrosis
|
NIDDK
|
2R01DK055835-09A1
|
|
Molecular Pathophysiology of Cystic Fibrosis
|
HWANG, TZYH-CHANG
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$294,764
|
Cystic Fibrosis
|
NCCAM
|
1R01AT004793-01
|
|
Quercetin and Innate Immune Responses in COPD
|
SAJJAN, UMADEVI
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$373,957
|
Cystic Fibrosis
|
NHLBI
|
1R21HL089196-01A2
|
|
The proton channel HVCN1 of the airways
|
FISCHER, HORST
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$234,000
|
Cystic Fibrosis
|
NIEHS
|
1R01ES016347-01A1
|
|
Dependency of O-3 Induced Lung Mucus Hypersecretion on NQ01
|
FOSTER, W
|
DUKE UNIVERSITY
|
NC
|
$340,416
|
Cystic Fibrosis
|
NIDDK
|
4R37DK044003-18
|
|
Molecular Genetics of Cystic Fibrosis
|
CUTTING, GARRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$391,765
|
Cystic Fibrosis
|
NHLBI
|
2R44HL074607-04A2
|
|
Rapid Cystic Fibrosis Mutation Screening Test
|
MANDECKI, WLODEK
|
PHARMASEQ, INC.
|
NJ
|
$999,802
|
Cystic Fibrosis
|
NHLBI
|
1R44HL093881-01
|
|
Development of a Humanized Pig Model of Cystic Fibrosis
|
ROGERS, CHRISTOPHER
|
PORCINOGEN, LLC
|
IA
|
$99,537
|
Cystic Fibrosis
|
NIAID
|
1R43AI079986-01
|
|
Therapeutics targeting fatty acid synthesis in P. aeruginosa
|
MOIR, DONALD
|
MICROBIOTIX, INC
|
MA
|
$300,000
|
Cystic Fibrosis
|
NHLBI
|
1R43HL094743-01
|
|
FilmArray High Resolution Melting Detection of Mutations Causing Cystic Fibrosis
|
TENG, DAVID
|
IDAHO TECHNOLOGY
|
UT
|
$147,105
|
Cystic Fibrosis
|
NIGMS
|
1F31GM085903-01A1
|
|
Influence of Solvent on the Active Site Environment of Lactoperoxidase
|
GREENE, JENNIFER
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$40,972
|
Cystic Fibrosis
|
NHLBI
|
1F32HL094000-01
|
|
Role of Stromelysin-2 in Mediating P. aeruginosa-induced Lung Inflammation
|
LIN, MICHELLE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$44,846
|
Cystic Fibrosis
|
NHLBI
|
1F33HL094051-01
|
|
New polymeric nanoparticles for Cystic Fibrosis gene therapy
|
JELINEK, RAZ
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$58,886
|
Cystic Fibrosis
|
NIGMS
|
1F32GM087635-01
|
|
Mutagenic double-strand break repair in Pseudomonas aeruginosa biofilms
|
PENTERMAN, JON
|
UNIVERSITY OF WASHINGTON
|
WA
|
$46,826
|
Cystic Fibrosis
|
NIDDK
|
5P30DK047754-15
|
0009
|
Pilot and Feasibility Program
|
MILLER, ARTHUR
|
UNIVERSITY OF WASHINGTON
|
WA
|
$171,556
|
Cystic Fibrosis
|
NIDDK
|
5P30DK047754-15
|
9002
|
Core--Animal
|
WILSON, CHRISTOPHER
|
UNIVERSITY OF WASHINGTON
|
WA
|
$101,927
|
Cystic Fibrosis
|
NIDDK
|
5P30DK047754-15
|
9005
|
Core--Human Applications
|
RAMSEY, BONNIE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$142,980
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051811-15
|
0001
|
Expression System with Adeno-Associated Viral Vectors
|
FLOTTE, TERENCE
|
UNIVERSITY OF FLORIDA GAINESVILLE
|
FL
|
$437,949
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051811-15
|
0003
|
Repeat Dosing of Adeno-Associated Viral Vectors
|
GUGGINO, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$454,495
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051670-15
|
0001
|
Adeno-Associated Virus-5 for Gene Transfer to CF Airway
|
WELSH, MICHAEL
|
UNIVERSITY OF IOWA
|
IA
|
$385,505
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051670-15
|
0004
|
Interactions of AAV5 with Sialic Acid and PDGF Receptors
|
ZABNER, JOSEPH
|
UNIVERSITY OF IOWA
|
IA
|
$333,915
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051670-15
|
0005
|
Targeting Entry in Epithelia with ICMV-FIV
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$307,714
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051670-15
|
0006
|
Development of a New Model for Cystic Fibrosis
|
WELSH, MICHAEL
|
UNIVERSITY OF IOWA
|
IA
|
$391,079
|
Cystic Fibrosis
|
NIDDK
|
1R43DK083171-01
|
|
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
|
SCHWIEBERT, ERIK
|
DISCOVERYBIOMED, LLC
|
AL
|
$100,000
|
Cystic Fibrosis
|
NHLBI
|
3R37HL036982-22S1
|
|
Mechanism of Oxidant-Induced Respiratory Mucin Secretion
|
ADLER, KENNETH
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
NC
|
$83,160
|
Cystic Fibrosis
|
NHLBI
|
1R01HL095396-01
|
|
Molecular Phenotypes for Cystic Fibrosis Lung Disease
|
KNOWLES, MICHAEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$758,962
|
Cystic Fibrosis
|
NIDDK
|
5P30DK065988-05
|
0003
|
Project 6
|
O'NEAL, WANDA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$70,914
|
Cystic Fibrosis
|
NIDDK
|
5P30DK065988-05
|
9002
|
Molecular Core
|
O'NEAL, WANDA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$156,559
|
Cystic Fibrosis
|
NIDDK
|
5P30DK065988-05
|
9003
|
Core--Imaging and Histology
|
DAVIS, C.
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$177,228
|
Cystic Fibrosis
|
NIDDK
|
5P30DK065988-05
|
9004
|
Core--Correction
|
GABRIEL, SHERIF
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$170,812
|
Cystic Fibrosis
|
NIDDK
|
5P30DK065988-05
|
9005
|
Core--Cell Culture Models
|
RANDELL, SCOTT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$149,651
|
Cystic Fibrosis
|
NIDDK
|
5P30DK027651-25
|
9015
|
Animal Core
|
DRUMM, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$281,425
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051818-15
|
0002
|
Equine Lentiviral Vector for Gene Delivery
|
OLSEN, JOHN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$378,267
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051818-15
|
0003
|
Respiratory Syncytial Virus Based Vectors for CFTR
|
PEEPLES, MARK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$508,114
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051818-15
|
9001
|
Core B--Tissue Procurement and Cell Culture Core
|
RANDELL, SCOTT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$156,021
|
Cystic Fibrosis
|
NHLBI
|
N01HV28187-12-0-1
|
|
National Heart, Lung, and Blood Institute Proteomics Initiative
|
NO PI IDENTIFIED
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$3,760,309
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051746-15
|
0006
|
AAV VECTORS BASED ION NEW SEROTYPES
|
GAO, G
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$295,401
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051746-15
|
0008
|
AAV-MEDIATED GENE THERAPY FOR CF USING SEGMENTAL TRANS-SPLICING
|
CRYSTAL, RG
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$388,703
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051746-15
|
0009
|
NOVEL LENTIVIRAL PSEUDOTYPES
|
WILLSON, JAMES
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$543,137
|
Cystic Fibrosis
|
NHLBI
|
5P01HL051746-15
|
9004
|
CORE --ANIMAL MODELS CORE
|
WIVEL, NELSON
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$554,482
|
Cystic Fibrosis
|
OD
|
2R56HL048282-10A2
|
|
Biosynthesis of Tracheal Mucous Glycoproteins
|
CHENG, PI-WAN
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$367,500
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084934-03
|
0001
|
The Mucus Transport Apparatus: Why Two Layers?
|
SHEEHAN, JOHN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$491,374
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084934-03
|
0002
|
ASL volume and innate defense in CF and COPD Airways
|
TARRAN, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$459,774
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084934-03
|
0003
|
Smoking and airway innate host defense: in vivo studies
|
PEDEN, DAVID
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$619,582
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084934-03
|
0005
|
Mucus Dehydration and Evolution of CF Lung Disease
|
DONALDSON, SCOTT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$397,982
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084934-03
|
9001
|
Mucociliary and Cough Clearance by Gamma Scintigraphy Core
|
BENNETT, WILLIAM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$351,195
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084934-03
|
9002
|
Administrative and Biostatistics Core
|
BOUCHER, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$303,425
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072517-04
|
9002
|
CORE--CLINICAL RESOURCES
|
NIELSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$136,085
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072517-04
|
9003
|
CORE--CELL MODELS
|
FINKBEINER, WALTER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$131,696
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072517-04
|
9004
|
CORE--MOUSE MODELS
|
VERKMAN, ALAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$80,481
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072517-04
|
9005
|
CORE--SYNTHETIC /MEDICINAL CHEMISTRY
|
KURTH, MARK
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$222,414
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072517-04
|
9006
|
CORE--CFTR BIOCHEMISTRY
|
LUKACS, GERGELY
|
UNIVERSITY OF TORONTO
|
CANADA
|
$117,604
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072517-04
|
9007
|
CORE--ELECTROPHYSIOLOGY
|
GALIETTA, LUIS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$98,727
|
Cystic Fibrosis
|
NHLBI
|
5P50HL084932-03
|
0001
|
Immune Tolerance and Inflammation in ABPA in Patients with Cystic Fibrosis
|
KOLLS, JAY
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$386,146
|
Cystic Fibrosis
|
NHLBI
|
3R01HL077546-03S1
|
|
The Virtual Lung Project: Integrated Modeling of Epithelial Fluid Flows
|
SUPERFINE, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$45,782
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072506-04
|
0001
|
Pilot 2
|
THIBODEAU, PATRICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$80,717
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072506-04
|
9001
|
CORE--HUMAN AIRWAY CELL PHYSIOLOGY
|
FRIZZEL, RAYMOND
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$276,000
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072506-04
|
9002
|
CORE--CLINICAL STUDIES AND OUTCOMES
|
KOLLS, JAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$274,341
|
Cystic Fibrosis
|
NIDDK
|
5P30DK072506-04
|
9004
|
CORE--PILOT AND FEASIBILITY PROGRAM
|
GAROFF, STEPHEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$106,880
|
Cystic Fibrosis
|
NIDDK
|
3P30DK054759-10S1
|
|
Center for Gene Therapy of Cystic Fibrosis and Other Ge*
|
ENGELHARDT, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$584,407
|
Cystic Fibrosis
|
NIDDK
|
3P30DK047757-15S1
|
|
MOLECULAR THERAPY FOR CF AND GENETIC DISEASES
|
WILSON, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$578,454
|
Cystic Fibrosis
|
NHLBI
|
5P01HL075161-04
|
0004
|
Adult Stem Cells Mediated Gene Therapy for Cystic Fibrosis
|
BUNNELL, BRUCE
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$397,499
|
Cystic Fibrosis
|
NHLBI
|
5P01HL034322-22
|
0011
|
Regulation of ENaC by Proteases and SGK1
|
STUTTS, MONROE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$394,420
|
Cystic Fibrosis
|
NHLBI
|
5P01HL034322-22
|
0012
|
Mechanisms of Nucleotide release by Airway Epithelia
|
LAZAROWSKI, EDUARDO
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$400,213
|
Cystic Fibrosis
|
NHLBI
|
5P01HL034322-22
|
0013
|
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume Homeostasis
|
BOUCHER, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$486,468
|
Cystic Fibrosis
|
NHLBI
|
5P01HL034322-22
|
9004
|
Imaging Core
|
CHUA, MICHAEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$139,945
|
Cystic Fibrosis
|
NHLBI
|
5P01HL034322-22
|
9006
|
Molecular and Protein Core
|
O'NEAL, WANDA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$200,078
|
Cystic Fibrosis
|
NHLBI
|
5P01HL034322-22
|
9007
|
Cell Culture Core
|
RANDELL, SCOTT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$121,072
|
Cystic Fibrosis
|
NCRR
|
2M01RR000997-33
|
6706
|
DOSE RANGING STUDY OF AN ORAL DURCUMIN/PIPERINE FORMULATION
|
PAI, VINAY
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$970
|
Cystic Fibrosis
|
NCRR
|
2M01RR000043-48
|
6815
|
PHARMACOGENOMICS OF MDR1 IN PATIENTS WITH CYSTIC FIBROSIS (CF)
|
BERINGER, PAUL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$116,567
|
Cystic Fibrosis
|
NCRR
|
2M01RR000043-48
|
6863
|
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TWO-TREATMENT, CROSSOVER STUD
|
WOO, MARILYN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$56,483
|
Cystic Fibrosis
|
NCRR
|
2M01RR000046-48
|
6911
|
COMPARISON OF ANTIBIOTICS FOR PSEUDOMONAS IN EARLY CF
|
NOAH, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$689
|
Cystic Fibrosis
|
NCRR
|
2M01RR000046-48
|
6922
|
EPIC CLINICAL TRIAL: PSEUDOMONAS AERUGINOSA AIRWAY INFECTION IN YOUNG CF PATIEN
|
RETSCH-BOGART, GEORGE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$76
|
Cystic Fibrosis
|
NCRR
|
2M01RR000046-48
|
6986
|
MUCUS CLEARANCE DURING ACUTE EXACERBATIONS OF CYSTIC FIBROSIS
|
DONALDSON, SCOTT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$3,367
|
Cystic Fibrosis
|
NCRR
|
2M01RR000046-48
|
7000
|
LONGITUDINAL STUDY OF PRIMARY CILIARY DYSKINESIA: SUBJECTS 5-18 YEARS OF AGE
|
LEIGH, MARGARET
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$995
|
Cystic Fibrosis
|
NCRR
|
2M01RR000046-48
|
7002
|
CLINICAL TRIAL: DENUFOSOL TETRASODIUM INHALATION SOLUTION IN PATIENTS WITH MILD
|
RETSCH-BOGART, GEORGE
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$3,290
|
Cystic Fibrosis
|
NCRR
|
2M01RR000046-48
|
7014
|
ASSOCIATION OF GENOTYPE AND CIRCULATING LEVELS OF TGF?1 IN CYSTIC FIBROSIS PA
|
KNOWLES, MICHAEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$10,177
|
Cystic Fibrosis
|
NCRR
|
5M01RR000082-46
|
7209
|
CLINICAL TRIAL: A MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED S
|
SPENCER, L
|
UNIVERSITY OF FLORIDA
|
FL
|
$541
|
Cystic Fibrosis
|
NCRR
|
5M01RR000082-46
|
7221
|
CLINICAL TRIAL: L2762G EFF OF NUTROPIN AQ FOR TRMT OF GROWTH RESTRICTION IN CHIL
|
STALVEY, MICHAEL
|
UNIVERSITY OF FLORIDA
|
FL
|
$2,167
|
Cystic Fibrosis
|
NCRR
|
5M01RR000400-40
|
7495
|
A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH
|
BILLINGS, JOANNE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$34,453
|
Cystic Fibrosis
|
NCRR
|
5M01RR000400-40
|
7503
|
INTENSIVE INSULIN THERAPY IN THE HOSPITALIZED CF PATIENT: A PILOT STUDY
|
MORAN, ANTOINETTE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$1,325
|
Cystic Fibrosis
|
NCRR
|
5M01RR000400-40
|
7520
|
INHALED SODIUM PYRUVATE FOR THE TREATMENT OF CYSTIC FIBROSIS A PHASE I, DOUBLE
|
BILLINGS, JOANNE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$3,092
|
Cystic Fibrosis
|
NCRR
|
5M01RR000400-40
|
7550
|
08-108: DENUFOSOL TETRASODIUM INHALATOIN SOLUTION IN MILD CF LUNG DISEASE
|
DUNITZ, JORDAN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$30,037
|
Cystic Fibrosis
|
NCRR
|
5M01RR000400-40
|
7557
|
MULTI-CENTER, MULTI-NATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AZITHROMYC
|
REGELMANN, WARREN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$13,693
|
|